Pharmaceuticals in China

Pharmaceuticals in China

Category : Pharmaceuticals
Sub Category : Pharmaceuticals Research and Development
December  2015  Pages : 34



TOLL FREE
+1-971-202-1575
------------ Or -------------
help@researchbeam.com
Summary
Pharmaceuticals in China industry profile provides top-line qualitative and quantitative Summary information including: market share, market size (value 2010-14, and forecast to 2019). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Essential resource for top-line data and analysis covering the China pharmaceuticals market. Includes market size data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.
- The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare. Market values have been calculated at ex-factory prices (the value at which manufacturers sell the drugs to distributors). Any currency conversions used in the production of this report have been calculated at constant 2014 annual average exchange rates.
- The Chinese pharmaceuticals market had total revenues of $94.4bn in 2014, representing a compound annual growth rate (CAGR) of 18.7% between 2010 and 2014.
- Chinas vast expansion of its basic healthcare program and list of accepted drugs is helping to produce very good growth for the pharmaceuticals industry; this state program now covers over a billion people in the country.
- The performance of the market is forecast to decelerate, with an anticipated CAGR of 15.2% for the five-year period 2014 - 2019, which is expected to drive the market to a value of $191.3bn by the end of 2019.

Key Findings Save time carrying out entry-level research by identifying the size, growth, and leading players in the pharmaceuticals market in China Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in China Leading company profiles reveal details of key pharmaceuticals market players global operations and financial performance Add weight to presentations and pitches by understanding the future growth prospects of the China pharmaceuticals market with five year forecasts Macroeconomic indicators provide insight into general trends within the China economy
Reasons To Buy What was the size of the China pharmaceuticals market by value in 2014? What will be the size of the China pharmaceuticals market in 2019? What factors are affecting the strength of competition in the China pharmaceuticals market? How has the market performed over the last five years? Who are the top competitiors in Chinas pharmaceuticals market?
TABLE OF CONTENTS
Executive Summary 2
Market value 2
Market value forecast 2
Geography segmentation 2
Market share 2
Market rivalry 2
Market Overview 7
Market definition 7
Market analysis 7
Market Data 8
Market value 8
Market Segmentation 9
Geography segmentation 9
Market share 10
Market Outlook 11
Market value forecast 11
Five Forces Analysis 12
Summary 12
Buyer power 13
Supplier power 15
New entrants 16
Threat of substitutes 18
Degree of rivalry 19
Leading Companies 21
AstraZeneca PLC 21
Pfizer Inc. 24
Jiangsu Yangtze River Pharmaceutical Group Company Ltd. 28
Macroeconomic Indicators 29
Country Data 29
Methodology 31
Industry associations 32
Related MarketLine research 32
Appendix 33
About MarketLine 33

List of Tables
Table 1: China pharmaceuticals market value: $ billion, 2010-14
Table 2: China pharmaceuticals market geography segmentation: $ billion, 2014
Table 3: China pharmaceuticals market share: % share, by value, 2014
Table 4: China pharmaceuticals market value forecast: $ billion, 2014-19
Table 5: AstraZeneca PLC: key facts
Table 6: AstraZeneca PLC: key financials ($)
Table 7: AstraZeneca PLC: key financial ratios
Table 8: Pfizer Inc.: key facts
Table 9: Pfizer Inc.: key financials ($)
Table 10: Pfizer Inc.: key financial ratios
Table 11: Jiangsu Yangtze River Pharmaceutical Group Company Ltd.: key facts
Table 12: China size of population (million), 2010-14
Table 13: China gdp (constant 2005 prices, $ billion), 2010-14
Table 14: China gdp (current prices, $ billion), 2010-14
Table 15: China inflation, 2010-14
Table 16: China consumer price index (absolute), 2010-14
Table 17: China exchange rate, 2010-14

List of Figures
Figure 1: China pharmaceuticals market value: $ billion, 2010-14
Figure 2: China pharmaceuticals market geography segmentation: % share, by value, 2014
Figure 3: China pharmaceuticals market share: % share, by value, 2014
Figure 4: China pharmaceuticals market value forecast: $ billion, 2014-19
Figure 5: Forces driving competition in the pharmaceuticals market in China, 2014
Figure 6: Drivers of buyer power in the pharmaceuticals market in China, 2014
Figure 7: Drivers of supplier power in the pharmaceuticals market in China, 2014
Figure 8: Factors influencing the likelihood of new entrants in the pharmaceuticals market in China, 2014
Figure 9: Factors influencing the threat of substitutes in the pharmaceuticals market in China, 2014
Figure 10: Drivers of degree of rivalry in the pharmaceuticals market in China, 2014
Figure 11: AstraZeneca PLC: revenues and profitability
Figure 12: AstraZeneca PLC: assets and liabilities
Figure 13: Pfizer Inc.: revenues and profitability
Figure 14: Pfizer Inc.: assets and liabilities

List Of Tables
N/A

List Of Figures
N/A
Enquiry Before Buy
image
Can´t read the image ? refresh here.